CervoMed Inc. (CRVO) stock
CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.46+0.13 (+9.77%)
Close on Nov 20, 2026Market cap $22.07MP/E –Yield –
CervoMed shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
CervoMed's shares outstanding was 10M at Jun 30, 2026. For fiscal 2025 it was 9M, up 12.0% from the year before. Over ten years it grew 103.3% a year on average. The highest annual figure on record is 9M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 9M | +12.0% |
| FY2024 | Dec 31, 2024 | 8M | +203.3% |
| FY2023 | Dec 31, 2023 | 3M | +413.6% |
| FY2022 | Dec 31, 2022 | 1M | -84.0% |
| FY2018 | Dec 31, 2018 | 3M | +282.3% |
| FY2017 | Dec 31, 2017 | 1M | +24.3% |
| FY2016 | Dec 31, 2016 | 1M | +290.6% |
| FY2015 | Dec 31, 2015 | 0M | +83.2% |
| FY2014 | Dec 31, 2014 | 0M | +440.3% |
| FY2013 | Dec 31, 2013 | 0M | +135.9% |
| FY2012 | Dec 31, 2012 | 0M | +11.1% |
| FY2011 | Dec 31, 2011 | 0M | +75.1% |
| FY2010 | Dec 31, 2010 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 10M | +14.5% |
| Q1 FY2026 | Mar 31, 2026 | 9M | +6.4% |
| Q4 FY2025 | Dec 31, 2025 | 9M | +6.3% |
| Q3 FY2025 | Sep 30, 2025 | 9M | +6.3% |
| Q2 FY2025 | Jun 30, 2025 | 9M | +2.8% |
| Q1 FY2025 | Mar 31, 2025 | 9M | +41.0% |
| Q4 FY2024 | Dec 31, 2024 | 9M | +131.2% |
| Q3 FY2024 | Sep 30, 2024 | 9M | +1579.6% |
| Q2 FY2024 | Jun 30, 2024 | 9M | +1579.6% |
| Q1 FY2024 | Mar 31, 2024 | 6M | +1090.9% |
| Q3 FY2023 | Sep 30, 2023 | 4M | +627.0% |
| Q2 FY2023 | Jun 30, 2023 | 1M | -74.6% |
| Q1 FY2023 | Mar 31, 2023 | 1M | -74.6% |
| Q4 FY2022 | Dec 31, 2022 | 1M | -74.6% |
| Q3 FY2022 | Sep 30, 2022 | 1M | -74.6% |
| Q2 FY2022 | Jun 30, 2022 | 2M | +23.6% |
| Q1 FY2022 | Mar 31, 2022 | 2M | -40.3% |
| Q3 FY2021 | Sep 30, 2021 | 2M | -39.6% |
| Q2 FY2021 | Jun 30, 2021 | 2M | -39.5% |
| Q1 FY2021 | Mar 31, 2021 | 2M | -41.2% |
| Q4 FY2018 | Dec 31, 2018 | 3M | +284.8% |
| Q3 FY2018 | Sep 30, 2018 | 3M | +243.7% |
| Q2 FY2018 | Jun 30, 2018 | 3M | +264.4% |
| Q1 FY2018 | Mar 31, 2018 | 3M | +307.5% |
| Q4 FY2017 | Dec 31, 2017 | 1M | +28.8% |
| Q3 FY2017 | Sep 30, 2017 | 1M | +42.4% |
| Q2 FY2017 | Jun 30, 2017 | 1M | – |
| Q1 FY2017 | Mar 31, 2017 | 1M | – |
| Q4 FY2016 | Dec 31, 2016 | 1M | – |
| Q3 FY2016 | Sep 30, 2016 | 1M | – |
See a number that looks wrong?